跳至主要内容
临床试验/NCT02344966
NCT02344966Unknown不适用

Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia

Yonsei University1 个研究点 分布在 1 个国家目标入组 1,100 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,100
试验地点
1
主要终点
Overall survival

研究概览

简要总结

The objective of this study is to evaluate the prognostic factors of acute leukemia patients and to invent the molecular genetic test for sensitive detection of minimal residual disease, and thereby this study would contribute to plan the risk adapted treatment. Patients will have samples of blood and/or bone marrow collected during diagnosis process, treatment and/or thereafter

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with acute leukemia in Severance Hospital.
  • Both genders of 16 Years and older
  • sign a written informed consent document

排除标准

  • No comprehension or willingness to sign a written informed consent document.

结局指标

主要结局

Overall survival

时间窗: 10years

Overall survival (OS) is defined as the time from date of diagnosis until death due to any cause within the follow-up period. Surviving patients are censored at date of last contact.

次要结局

  • Progression-free survival(10years)
  • Treatment-related mortality(10years)
  • Complete remission rate(10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验